Aspirin/clopidogrel/warfarin

Aspirin/clopidogrel/warfarin Reactions 1680, p58 - 2 Dec 2017 Epistaxis and gastrointestinal bleeding: 3 case report In a single centre retrospective study of 16 patients, three patients (two men and one woman), aged between 55-85 years were described, who developed epistaxis (two patients) during treatment with aspirin and clopidogrel and gastrointestinal bleeding (one patient) during treatment with warfarin [route, dosage and duration of treatment to reaction onset not stated]. A 76-year-old man, who had a history of factor XI deficiency (FXID) with FXI coagulant activity of 7%, received chronic treatment with aspirin and clopidogrel for coronary artery disease with stents. He developed epistaxis and subsequently therapy with clopidogrel was discontinued. A 55-year-old man, who had a history of factor XI deficiency (FXID) with FXI coagulant activity of 31%, received six months treatment with warfarin for portal vein thrombosis. He developed gastrointestinal bleeding and subsequently therapy with warfarin was discontinued. An 85-year-old woman, who had a history of factor XI deficiency (FXID) with FXI coagulant activity of 1%, received chronic treatment with aspirin and clopidogrel for acute coronary syndrome prophylaxis. She developed epistaxis and subsequently therapy with clopidogrel was discontinued. Author comment: "Four patients with factor XI deficiency had bleeding related to anticoagulants (warfarin)/antiplatelet (clopidogrel, aspirin) agent exposure, two with partial and two with severe deficiency." Chapin J, et al. The safety of chronic antithrombotic therapy in patients with factor XI deficiency. British Journal of Haematology 179: 506-508, No. 3, Nov 2017. Available from: URL: http://doi.org/10.1111/bjh.14227 - USA 803284487 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Aspirin/clopidogrel/warfarin

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/aspirin-clopidogrel-warfarin-lOp07UnsHt
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-38989-1
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p58 - 2 Dec 2017 Epistaxis and gastrointestinal bleeding: 3 case report In a single centre retrospective study of 16 patients, three patients (two men and one woman), aged between 55-85 years were described, who developed epistaxis (two patients) during treatment with aspirin and clopidogrel and gastrointestinal bleeding (one patient) during treatment with warfarin [route, dosage and duration of treatment to reaction onset not stated]. A 76-year-old man, who had a history of factor XI deficiency (FXID) with FXI coagulant activity of 7%, received chronic treatment with aspirin and clopidogrel for coronary artery disease with stents. He developed epistaxis and subsequently therapy with clopidogrel was discontinued. A 55-year-old man, who had a history of factor XI deficiency (FXID) with FXI coagulant activity of 31%, received six months treatment with warfarin for portal vein thrombosis. He developed gastrointestinal bleeding and subsequently therapy with warfarin was discontinued. An 85-year-old woman, who had a history of factor XI deficiency (FXID) with FXI coagulant activity of 1%, received chronic treatment with aspirin and clopidogrel for acute coronary syndrome prophylaxis. She developed epistaxis and subsequently therapy with clopidogrel was discontinued. Author comment: "Four patients with factor XI deficiency had bleeding related to anticoagulants (warfarin)/antiplatelet (clopidogrel, aspirin) agent exposure, two with partial and two with severe deficiency." Chapin J, et al. The safety of chronic antithrombotic therapy in patients with factor XI deficiency. British Journal of Haematology 179: 506-508, No. 3, Nov 2017. Available from: URL: http://doi.org/10.1111/bjh.14227 - USA 803284487 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off